Drug Profile
Emitefur
Alternative Names: BOF A2; Last-FLatest Information Update: 20 Oct 2006
Price :
$50
*
At a glance
- Originator Otsuka Pharmaceutical
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Breast cancer; Colorectal cancer; Gastrointestinal cancer; Lung cancer; Non-small cell lung cancer; Pancreatic cancer